Aladdin®Metabolites

posted this at Jun 9, 2025 Updated at Nov 24, 2024

Product Manager：Harrison Michael

Introduction

Metabolites are intermediate or end products produced during the metabolic processes of organisms and are widely present in cells, tissues, and body fluids. As "chemical signals" of life activities, metabolites not only participate in and regulate important physiological and biochemical processes but also play a key role in disease diagnosis, drug development, and the discovery of biomarkers. By studying metabolites, we can reveal the operating mechanisms of biological systems, providing important basis for basic biological research and clinical medical applications.

Metabolites have a wide range of applications in scientific research. They are used for metabolic pathway analysis, enzyme activity detection, metabolomics studies, and the design and screening of new drugs. Especially in the fields of metabolic diseases, cancer, and infectious diseases, the study of metabolic ligands provides a powerful tool for revealing pathological mechanisms and developing precise medical solutions.

Aladdin Scientific is committed to providing high-quality metabolite products for researchers. This article summarizes Aladdin Scientific's selected catalog of metabolite products, covering a high-quality collection of endogenous and exogenous metabolites, providing multifunctionality, reliability, and precision support for scientific researchers. These metabolites are not only suitable for research on metabolic diseases, cancer, and infectious diseases but also provide a solid foundation for the development of new therapies and industry technological advancement. We believe that these high-quality metabolite products will become a strong assistant in your scientific research, helping to achieve research goals.

Activator

Target	Cat.No	CAS	Product Name	Specification/Purity	Action
AMP kinase	A136967	61-19-8	5'-Adenylic Acid	≥98%(HPLC)	Activator
carbonic anhydrase 1	E113174	51-43-4	L-Adrenaline	98%	Activator
carbonic anhydrase 1,5A,7	H111796	51-45-6	Histamine, Free Base	96%	Activator
carbonic anhydrase 1,14,5A,7	H108261	71-00-1	L-Histidine	EP,USP, non-animal source, for cell culture	Activator
CatSper1,2,3,4	P129960	745-65-3	Prostaglandin E1	≥98%(HPLC)	Full agonist
CatSper1,2,3,4	D133402	363-24-6	Dinoprostone	98%	Full agonist
CatSper1,2,3,4	P336179	745-62-0	PGF1α (Prostaglandin F1α)	98%	Full agonist
CatSper1,2,3,4	P106427	57-83-0	Progesterone	USP	Full agonist
ClC-2	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Others
CNGA1,2,3	G349525	7665-99-8	Guanosine 3′,5′-cyclic monophosphate	≥98%	Agonist
CNGA2,3	C107047	60-92-4	Adenosine 3′,5′-cyclic monophosphate	99%	Agonist
HCN1,2	C107047	60-92-4	Adenosine 3′,5′-cyclic monophosphate	99%	Agonist
HCN2	G349525	7665-99-8	Guanosine 3′,5′-cyclic monophosphate	≥98%	Agonist
IP3R1	A501266	56-65-5	Adenosine triphosphate	90%	Others
IP3R1,2,3	P486700	142656-03-9	Poly(Disperse Red 13 acrylate)		Others
K2P10.1,13.1	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Others
K2P10.1	D100925	6217-54-5	Cervonic Acid	≥98%	Others
K2P10.1	L100446	60-33-3	Linoleic acid	Analytical standard,≥99.0%(GC)	Others
K2P16.1,2.1	C153359	26675-46-7	1-Chloro-2,2,2-trifluoroethyl Difluoromethyl Ether	>98.0%(GC)	Others
K2P2.1	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Activator
K2P2.1,3.1	C153359	26675-46-7	1-Chloro-2,2,2-trifluoroethyl Difluoromethyl Ether	>98.0%(GC)	Positive
K2P4.1	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Positive
KCa1.1	E110147	50-28-2	β-Estradiol	Analytical standard,99.5%	Others
KCa2.3,3.4	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Agonist
Kir6.1	A501266	56-65-5	Adenosine triphosphate	90%	Agonist
Kv2.1	L100446	60-33-3	Linoleic acid	Analytical standard,≥99.0%(GC)	Others
L-Phenylalanine hydroxylase	T305191	17528-72-2	Tetrahydrobiopterin	≥98%	Activator
phosphodiesterase 2A	G349525	7665-99-8	Guanosine 3′,5′-cyclic monophosphate	≥98%	Activator
PLD2	O108486	112-80-1	Oleic acid	Analytical standard,≥99.0%(GC)	Activator
protein kinase C zeta	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Activator
RyR1,2,3	A501266	56-65-5	Adenosine triphosphate	90%	Others
TRPA1	H274882	75899-68-2	4-Hydroxynonenal	≥97%	Activator
TRPA1	O274680	103560-62-9	4-Oxo-2-nonenal (4-ONE)	95%	Activator
TRPA1	A433552	75-07-0	Acetaldehyde	ACS reagent, ≥99.5%	Activator
TRPA1	D100925	6217-54-5	Cervonic Acid	≥98%	Activator
TRPA1	C153359	26675-46-7	1-Chloro-2,2,2-trifluoroethyl Difluoromethyl Ether	>98.0%(GC)	Activator
TRPA1	M109036	78-98-8	Methylglyoxal	32% solution	Activator
TRPA1	P275095	13345-50-1	Prostaglandin A2	≥98%	Activator
TRPA1	M105139	89-78-1	DL-Menthol	Analytical standard	Partial agonist
TRPC2	S397171	60514-48-9	1,2-Dioctanoyl-sn-glycerol	99%	Agonist
TRPC2	S347974	65914-84-3	1-Stearoyl-2-arachidonoyl-sn-glycerol	95%，25mg/ml in methyl acetate	Agonist
TRPC5	M420133	83-43-2	6-α-Methylprednisolone	98%	Activator
TRPC6	S347974	65914-84-3	1-Stearoyl-2-arachidonoyl-sn-glycerol	95%，25mg/ml in methyl acetate	Agonist
TRPC6	H126988	79551-86-3	20-HETE	≥90%(HPLC)	Others
TRPC6	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Others
TRPC7	S397171	60514-48-9	1,2-Dioctanoyl-sn-glycerol	99%	Agonist
TRPM2	N348628	5502-96-5	Nicotinic acid adenine dinucleotide phosphate sodium salt	≥92%	Agonist
TRPM2	N432853	53-84-9	β-Nicotinamide adenine dinucleotide hydrate	≥95% (HPLC)	Agonist
TRPM2	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Fortifier
TRPM3	D130610	764-22-7	D-erythro-sphinganine	>99%	Agonist
TRPM3	D130604	123-78-4	D-erythro-sphingosine	>99%	Agonist
TRPM8	M105139	89-78-1	DL-Menthol	Analytical standard	Partial agonist
TRPP2	C108872	77-92-9	Citrate	Analytical standard	Agonist
TRPV1	H336047	71774-10-2	12(S)-HPETE	50 μg/ml in ethanol,≥98%	Agonist
TRPV1	H342777	71774-08-8	5(S)-HPETE	100 ug/mL in ethanol	Agonist
TRPV1	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Agonist
TRPV1	A288783	128007-31-8	Arvanil	≥98%(HPLC)	Agonist
TRPV1	L275630	71160-24-2	Leukotriene B4	≥95%,~10 µg/ml in ethanol，Analytical standard	Agonist
TRPV1	H336630	70608-72-9	5(S)-HETE	50 μg/ml in ethanol	Others
TRPV3	M105139	89-78-1	DL-Menthol	Analytical standard	Activator
TRPV4	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Activator
TRPV4	C108872	77-92-9	Citrate	Analytical standard	Agonist
TRPV6	A433552	75-07-0	Acetaldehyde	ACS reagent, ≥99.5%	Activator

Agonist

Target	Cat.No	CAS	Product Name	Specification/Purity	Action
GABAB,GABAB1receptor	A104200	56-12-2	γ-Aminobutyric acid	99%	Full agonist
Glycine Receptor (All subtypes)	A104200	56-12-2	γ-Aminobutyric acid	99%	Partial agonist
GluN1,2A,2B,2C,2D	A105951	1783-96-6	D-Aspartic acid	98%	Agonist
Adenosine A1,A2A,A2B,A3 receptor	A108808	58-61-7	Adenosine	Ultra pure grade,99.5%	Agonist
GluN1,2A2B,2C,2D	A110750	56-40-6	Aminoacetic acid	Analytical standard	Agonist
Glycine Receptor (All subtypes)	A110750	56-40-6	Aminoacetic acid	Analytical standard	Agonist
GPRC6 receptor	A110750	56-40-6	Aminoacetic acid	Analytical standard	Full agonist
GPRC6 receptor	A118651	74-79-3	L-Arginine	Non-animal origin, EP, USP; For cell culture, 98.5 to 101.0%	Full agonist
P2Y1,P2Y12,P2Y13 receptor	A119474	58-64-0	Adenosine 5′-diphosphate	≥95% (HPLC)	Full agonist
P2Y11 receptor	A119474	58-64-0	Adenosine 5′-diphosphate	≥95% (HPLC)	Agonist
P2Y6 receptor	A119474	58-64-0	Adenosine 5′-diphosphate	≥95% (HPLC)	Partial agonist
GluN1,2A,2B,2C,2D	A137730	56-84-8	L-Aspartic acid	98%	Agonist
Glycine Receptor (All subtypes)	A137901	107-95-9	β-Alanine	98%	Partial agonist
MRGPRD	A137901	107-95-9	β-Alanine	98%	Full agonist
CB1 receptor	A274643	229021-64-1	ACPA (Arachidonylcyclopropylamide)	≥98%	Full agonist
GPR18	A274643	229021-64-1	ACPA (Arachidonylcyclopropylamide)	≥98%	Agonist
CB1,CB2 receptor	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Partial agonist
GPR18	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Full agonist
GPR55	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Agonist
GPR18	A275341	179113-91-8	N-Arachidonylglycine (NAGly)	≥98%	Full agonist
LPA5 receptor	A275341	179113-91-8	N-Arachidonylglycine (NAGly)	≥98%	Partial agonist
GPR17	A501266	56-65-5	Adenosine triphosphate	90%	Agonist
P2X1,2,3,4,5,6,7	A501266	56-65-5	Adenosine triphosphate	90%	Agonist
P2Y1,P2Y4 receptor	A501266	56-65-5	Adenosine triphosphate	90%	Partial agonist
P2Y11,P2Y13,P2Y2 receptor	A501266	56-65-5	Adenosine triphosphate	90%	Full agonist
P2Y4 receptor	A501266	56-65-5	Adenosine triphosphate	90%	Agonist
FFA2,FFA3 receptor	B110439	107-92-6	Butyric acid	Standard for GC,>99.5%(GC)	Full agonist
HCA2 receptor	B110439	107-92-6	Butyric acid	Standard for GC,>99.5%(GC)	Agonist
Glucocorticoid receptor	B121764	378-44-9	Betamethasone Solutiom	1.00mg/ml	Full agonist
Adenosine A1,A2A,A2B,A3 receptor	C103231	146-77-0	2-Chloroadenosine	99%	Full agonist
Farnesoid X receptor	C103692	81-25-4	Cholic acid	Analytical standard,>98%	Agonist
GPBA receptor	C103692	81-25-4	Cholic acid	Analytical standard,>98%	Full agonist
RAR-related orphan receptor-α	C104029	57-88-5	Cholesterol	Analytical standard,99.0%	Agonist
Farnesoid X receptor	C104903	474-25-9	Chenodeoxycholic acid	Analytical standard	Agonist
GPBA receptor	C104903	474-25-9	Chenodeoxycholic acid	Analytical standard	Full agonist
Farnesoid X receptor-β	C105355	67-97-0	Cholecalciferol (D3)	Analytical standard	Agonist
GPRC6 receptor	C109228	372-75-8	L-Citrulline	98%	Full agonist
Glucocorticoid receptor	C119329	50-22-6	Corticosterone	Analytical standard	Agonist
Mineralocorticoid receptor	C119329	50-22-6	Corticosterone	Analytical standard	Agonist
Vitamin D receptor	C120126	32222-06-3	calcitriol	97%	Agonist
GPR183	C130176	2140-46-7	cholest-5-ene-3,25-diol	>99%	Agonist
RAR-related orphan receptor-γ	C130176	2140-46-7	cholest-5-ene-3,25-diol	>99%	Agonist
GPR183	C130177	20380-11-4	cholest-(25R)-5-ene-3β,27-diol	>99%	Agonist
Liver X receptor-α,β	C130177	20380-11-4	cholest-(25R)-5-ene-3β,27-diol	>99%	Agonist
GPR183	C130186	566-26-7	cholest-5-en-3β,7α-diol	>98%	Agonist
GPR183	C130187	566-27-8	7β-Hydroxycholesterol	>99%	Agonist
Liver X receptor-α,β	C130207	474-73-7	cholest-5-ene-3β,24(S)-diol	>99%	Agonist
Stimulator of interferon response cGAMP interactor 1	C413868	1441190-66-4	2',3'-cGAMP Sodium Salt	98%	Agonist
FFA1 receptor	D100925	6217-54-5	Cervonic Acid	≥98%	Full agonist
Retinoid X receptor-α	D100925	6217-54-5	Cervonic Acid	≥98%	Agonist
Farnesoid X receptor	D103698	83-44-3	Deoxycholic acid	Analytical standard,>99%	Agonist
GPBA receptor	D103698	83-44-3	Deoxycholic acid	Analytical standard,>99%	Full agonist
Estrogen receptor-α,β	D109025	56-53-1	Diethylstilbestrol	99%	Agonist
GPR84	D109189	334-48-5	Decanoic acid	Standard for GC,>99%(GC)	Full agonist
GPR143	D111049	59-92-7	L-dopa	Analytical standard,>99%	Agonist
Vitamin D receptor	D120130	54573-75-0	Doxercalciferol	98%	Agonist
GPR183	D130181	240129-43-5	7β,27-dihydroxycholesterol	>99%	Agonist
GPR183	D130221	64907-22-8	7α,25-dihydroxycholesterol	>98%	Full agonist
GPR1,2,3,6,63	D130606	26993-30-6	D-erythro-sphingosine-1-phosphate	≥98.0%	Full agonist
P2RY10	D130606	26993-30-6	D-erythro-sphingosine-1-phosphate	≥98.0%	Agonist
S1P1,S1P2,S1P3,S1P4,S1P5 receptor	D130606	26993-30-6	D-erythro-sphingosine-1-phosphate	≥98.0%	Agonist
DP1,DP2 receptor	D133402	363-24-6	Dinoprostone	98%	Full agonist
EP1,EP2,EP3,EP4 receptor	D133402	363-24-6	Dinoprostone	98%	Full agonist
FP receptor	D133402	363-24-6	Dinoprostone	98%	Full agonist
TP receptor	D133402	363-24-6	Dinoprostone	98%	Full agonist
Glucocorticoid receptor	D133972	64-85-7	11-Deoxy Corticosterone	≥97% (HPLC)	Agonist
Mineralocorticoid receptor	D133972	64-85-7	11-Deoxy Corticosterone	≥97% (HPLC)	Agonist
Alpha-2B adrenoceptor	D274858	329-65-7	DL-Adrenaline (Racepinephrine)	98%	Partial agonist
Alpha-2C adrenoceptor	D274858	329-65-7	DL-Adrenaline (Racepinephrine)	98%	Full agonist
Beta-1,Beta-3 adrenoceptor	D274858	329-65-7	DL-Adrenaline (Racepinephrine)	98%	Full agonist
EP4 receptor	D274874	19313-28-1	13,14-Dihydroprostaglandin E1	≥98%	Full agonist
Peroxisome proliferator-activated receptor-γ	D275807	87893-55-8	15-Deoxy-Delta12	≥97%	Full agonist
P2Y11 receptor	D276527	1927-31-7	2'-Deoxyadenosine 5'-triphosphate [dATP] trisodium salt trihydrate	≥98%	Full agonist
EP2,EP3,EP4 receptor	D334664	37786-00-8	11-deoxy Prostaglandin E1	≥96%	Full agonist
Glucocorticoid receptor	D336852	382-67-2	Desoximetasone	≥98%	Agonist
DP2 receptor	D355691	85235-11-6	15-deoxy-δ12,14-Prostaglandin D2	A solution in methyl acetate	Full agonist
DP2 receptor	D356084	27376-76-7	13,14-Dihydro-15-keto-prostaglandin F2α	A solution in methyl acetate,≥95%	Full agonist
D1,D2,D3,D4,D5 receptor	D590946	51-61-6	Dopamine	95%	Full agonist
Estrogen receptor-α,β	E105514	50-27-1	Estriol	Analytical standard	Agonist
Estrogen receptor-α,β	E105516	53-16-7	Estrone	Analytical standard	Agonist
Estrogen receptor-α,β	E110147	50-28-2	β-Estradiol	Analytical standard,99.5%	Agonist
GPER	E110147	50-28-2	β-Estradiol	Analytical standard,99.5%	Full agonist
Pregnane X receptor	E110147	50-28-2	β-Estradiol	Analytical standard,99.5%	Agonist
Alpha-1A,1B,1D,2A adrenoceptor	E113174	51-43-4	L-Adrenaline	98%	Full agonist
Alpha-2B,2C adrenoceptor	E113174	51-43-4	L-Adrenaline	98%	Agonist
Beta-1,3 adrenoceptor	E113174	51-43-4	L-Adrenaline	98%	Agonist
Beta-2 adrenoceptor	E113174	51-43-4	L-Adrenaline	98%	Full agonist
Estrogen receptor-α,β	E129595	57-63-6	Ethinyl Estradiol	≥98%	Agonist
Peroxisome proliferator-activated receptor-α	E274770	1191-85-1	5,8,11,14-Eicosatetraynoic acid	≥98%	Agonist
BLT2 receptor	E349093	83709-73-3	12-epi Leukotriene B4	A solution in ethanol	Partial agonist
Glucocorticoid receptor	H110523	50-23-7	Hydrocortisone	98%	Agonist
Mineralocorticoid receptor	H110523	50-23-7	Hydrocortisone	98%	Agonist
H1,H2,H3,H4 receptor	H111796	51-45-6	Histamine, Free Base	96%	Full agonist
GPR84	H275247	1883-13-2	3-Hydroxydodecanoic acid	≥98%	Full agonist
BLT2 receptor	H276042	54845-95-3	15(S)-HETE	~100μg/mL in ethanol，98%	Partial agonist
GPR84	H276183	2984-55-6	2-Hydroxydodecanoic acid	95%	Full agonist
GPR84	H276520	5393-81-7	2-Hydroxydecanoic acid	≥98%	Full agonist
5-HT,5-HT1B,5-HT1D,5-HT1E,5-HT1F,5-HT2A,5-HT2B,5-HT2C,5-HT4,5-HT5A,5-HT6,5-HT7 receptor	H303833	50-67-9	5-Hydroxytryptamine	≥98%（HPLC）	Full agonist
5-HT3A	H303833	50-67-9	5-Hydroxytryptamine	≥98%（HPLC）	Agonist
5-HT3AB	H303833	50-67-9	5-Hydroxytryptamine	≥98%（HPLC）	Agonist
D1 receptor	H303833	50-67-9	5-Hydroxytryptamine	≥98%（HPLC）	Partial agonist
D5 receptor	H303833	50-67-9	5-Hydroxytryptamine	≥98%（HPLC）	Full agonist
GPR132	H336037	73543-67-6	9(S)-HODE	A solution in ethanol,≥98%	Full agonist
OXE receptor	H336630	70608-72-9	5(S)-HETE	50 μg/ml in ethanol	Full agonist
OXE receptor	H342777	71774-08-8	5(S)-HPETE	100 ug/mL in ethanol	Full agonist
Peroxisome proliferator-activated receptor-α	H342781	98462-03-4	8(S)-HETE	50 μg/ml in ethanol	Agonist
BLT2 receptor	H342782	54397-83-0	12(S)-HETE	~100μg/mL in ethanol，98%	Partial agonist
GPR31	H342782	54397-83-0	12(S)-HETE	~100μg/mL in ethanol，98%	Full agonist
Farnesoid X receptor-β	H400267	313-04-2	3β-hydroxy-5,24-cholestadiene	98%	Agonist
Liver X receptor-α,β	H400267	313-04-2	3β-hydroxy-5,24-cholestadiene	98%	Agonist
FFA2,FFA3 receptor	I103521	79-31-2	Isobutyric acid	Standard for GC,≥99.5%(GC)	Full agonist
TAAR3	I109581	107-85-7	Isopentylamine	99%	Full agonist
Oxoglutarate receptor	K105570	328-50-7	α-Ketoglutaric acid	99%, for cell culture	Full agonist
GPR35	K120012	492-27-3	Kynurenic acid	97%	Agonist
FFA1,FFA4 receptor	L100446	60-33-3	Linoleic acid	Analytical standard,≥99.0%(GC)	Full agonist
Hepatocyte nuclear factor-4-α	L100446	60-33-3	Linoleic acid	Analytical standard,≥99.0%(GC)	Full agonist
Peroxisome proliferator-activated receptor-γ	L100446	60-33-3	Linoleic acid	Analytical standard,≥99.0%(GC)	Full agonist
GPRC6 receptor	L103479	56-87-1	L-Lysine	98%	Full agonist
FFA1,FFA4 receptor	L105575	463-40-1	Linolenic acid	99%	Full agonist
Farnesoid X receptor	L106779	434-13-9	Lithocholic acid	>97.0%	Agonist
GPBA receptor	L106779	434-13-9	Lithocholic acid	>97.0%	Full agonist
Pregnane X receptor	L106779	434-13-9	Lithocholic acid	>97.0%	Agonist
Vitamin D receptor	L106779	434-13-9	Lithocholic acid	>97.0%	Agonist
HCA1 receptor	L107595	79-33-4	L-Lactic Acid	80%	Full agonist
GPR84	L110739	143-07-7	Lauric acid	standard for GC,≥99.5%(GC)	Agonist
Farnesoid X receptor-β	L130208	79-63-0	Lanosterol	>95%	Agonist
CysLT1,CysLT2 receptor	L274987	75715-89-8	Leukotriene E4	≥97%,100ug/ml in ethanol	Partial agonist
GPR17	L274987	75715-89-8	Leukotriene E4	≥97%,100ug/ml in ethanol	Agonist
CysLT1,CysLT2 receptor	L275222	72025-60-6	Leukotriene C4	≥97%，A solution in ethanol	Full agonist
GPR17	L275222	72025-60-6	Leukotriene C4	≥97%，A solution in ethanol	Agonist
BLT1 receptor	L275630	71160-24-2	Leukotriene B4	≥95%,~10 µg/ml in ethanol，Analytical standard	Full agonist
BLT2 receptor	L275630	71160-24-2	Leukotriene B4	≥95%,~10 µg/ml in ethanol，Analytical standard	Partial agonist
Peroxisome proliferator-activated receptor-α	L275630	71160-24-2	Leukotriene B4	≥95%,~10 µg/ml in ethanol，Analytical standard	Agonist
FPR2/ALX	L342353	171030-11-8	15(R)-Lipoxin A4	≥95%，~100ug/ml in ethanol	Full agonist
FPR2/ALX,FPR3	L345922	89663-86-5	Lipoxin A4	≥95%，100µg/ml in ethanol	Full agonist
GPR32	L345922	89663-86-5	Lipoxin A4	≥95%，100µg/ml in ethanol	Full agonist
GPRC6 receptor	L413185	70-26-8	L-Ornithine	95%	Full agonist
MT1,MT2 receptor	M118674	73-31-4	Melatonin	98%	Full agonist
GPER	M125960	362-07-2	2-Methoxyestradiol (2-MeOE2)	≥98%	Agonist
Vitamin D receptor	M127999	103909-75-7	Maxacalcitol	≥98%	Agonist
PAF receptor	M275051	91575-58-5	Methylcarbamyl-PAF	≥98%	Agonist
Glucocorticoid receptor	M420133	83-43-2	6-α-Methylprednisolone	98%	Agonist
FFA1,FFA4 receptor	M432884	544-63-8	Myristic acid	For synthesis	Full agonist
nucleotide binding oligomerization domain containing 1	M465023	922-54-3	meso-2,6-Diaminopimelic acid	≥98% (TLC)	Agonist
TA1 receptor	M474350	582-22-9	β-Methylphenethylamine	99%	Agonist
HCA1 receptor	N103654	59-67-6	Nicotinic acid	Analytical standard,≥99.5% (HPLC)	Agonist
HCA2,HCA3 receptor	N103654	59-67-6	Nicotinic acid	Analytical standard,≥99.5% (HPLC)	Full agonist
Alpha-1A,1B,1D,2A,2C adrenoceptor	N109573	51-41-2	L-Noradrenaline	98%	Full agonist
Alpha-2B adrenoceptor	N109573	51-41-2	L-Noradrenaline	98%	Partial agonist
Beta-1,2 adrenoceptor	N109573	51-41-2	L-Noradrenaline	98%	Agonist
Beta-3 adrenoceptor	N109573	51-41-2	L-Noradrenaline	98%	Full agonist
GPR119	N135851	544-31-0	Palmitoylethanolamide	≥98%	Full agonist
GPR55	N135851	544-31-0	Palmitoylethanolamide	≥98%	Agonist
GPR55	N276283	222723-55-9	Noladin ether	≥98%	Agonist
P2Y11 receptor	N348628	5502-96-5	Nicotinic acid adenine dinucleotide phosphate sodium salt	≥92%	Full agonist
P2Y11 receptor	N432853	53-84-9	β-Nicotinamide adenine dinucleotide hydrate	≥95% (HPLC)	Full agonist
TA1 receptor	O101521	770-05-8	(±)-Octopamine hydrochloride	98%	Full agonist
FFA1,FFA4 receptor	O108486	112-80-1	Oleic acid	Analytical standard,≥99.0%(GC)	Full agonist
PAF receptor	O130783	74389-68-7	1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine	≥98%	Full agonist
OXE receptor	O275056	106154-18-1	5-Oxoete (5-Ketoeicosa-6E,8Z,11Z,14E-tetraenoic acid)	≥95%	Full agonist
GPR119	O287241	105955-11-1	OLDA	96%	Agonist
Pregnane X receptor	O351925	1553-56-6	3-Oxo-5β-cholanoic Acid	95%	Agonist
Vitamin D receptor	O351925	1553-56-6	3-Oxo-5β-cholanoic Acid	95%	Agonist
BLT1 receptor	O353437	79516-82-8	20-OH-LTB4	50 μg/ml in ethanol,≥99%	Full agonist
FFA1 receptor	P101058	57-10-3	Palmitic acid	Analytical standard,>99%(GC)	Full agonist
Progesterone receptor	P106427	57-83-0	Progesterone	USP	Agonist
HCA3 receptor	P109094	673-06-3	D-Phenylalanine	98%	Full agonist
GPR139	P110424	63-91-2	L-Phenylalanine	99%	Agonist
FFA2,FFA3 receptor	P110446	79-09-4	Propionic acid	Analytical standard	Full agonist
Glucocorticoid receptor	P116562	53-03-2	Prednisone	98%	Full agonist
Vitamin D receptor	P126516	131918-61-1	Paricalcitol	≥99%	Agonist
DP1 receptor	P129960	745-65-3	Prostaglandin E1	≥98%(HPLC)	Full agonist
EP1,EP2,EP3,EP4 receptor	P129960	745-65-3	Prostaglandin E1	≥98%(HPLC)	Full agonist
IP receptor	P129960	745-65-3	Prostaglandin E1	≥98%(HPLC)	Full agonist
GPR119	P130493	17364-16-8	1-Palmitoyl-sn-glycero-3-phosphocholine	>99%	Agonist
DP1,DP2 receptor	P275004	60203-57-8	Prostaglandin J2	95%，5 mg/mL in methyl acetate	Full agonist
DP1,DP2 receptor	P275206	41598-07-6	Prostaglandin D2	≥99%	Full agonist
EP1,EP2,EP3,EP4 receptor	P275206	41598-07-6	Prostaglandin D2	≥99%	Full agonist
FP receptor	P275206	41598-07-6	Prostaglandin D2	≥99%	Full agonist
EP1,EP2,EP3 receptor	P336631	38315-43-4	17-phenyl trinor Prostaglandin E₂	98%	Full agonist
EP4 receptor	P336631	38315-43-4	17-phenyl trinor Prostaglandin E₂	98%	Agonist
DP1,DP2 receptor	P339275	87893-54-7	Δ12-PGJ2 (Δ12-Prostaglandin J2)	A solution in methyl acetate,98%	Full agonist
Retinoid X receptor-α	P348349	14721-66-5	Phytanic Acid	A solution in ethanol,>96%	Agonist
Peroxisome proliferator-activated receptor-α	P348795	1189-37-3	Pristanic acid solution	Solution in Ethanol (10mg/ml)	Agonist
Peroxisome proliferator-activated receptor- β/δ	R106321	302-79-4	Retinoic acid	Analytical standard	Full agonist
RAR-related orphan receptor-β	R106321	302-79-4	Retinoic acid	Analytical standard	Agonist
Retinoic acid receptor-α,β,γ	R106321	302-79-4	Retinoic acid	Analytical standard	Agonist
Testicular receptor 4	R106321	302-79-4	Retinoic acid	Analytical standard	Full agonist
TLX	R106321	302-79-4	Retinoic acid	Analytical standard	Agonist
GPR84	R133494	5561-87-5	(±)-3-Hydroxydecanoic acid	≥98%	Full agonist
chemerin receptor 1	R331811	1309610-43-2	Resolvin E1 Sodium Salt		Full agonist
FPR2/ALX	R341442	872993-05-0	Resolvin D1	A solution in ethanol,≥95%	Full agonist
GPR32	R341442	872993-05-0	Resolvin D1	A solution in ethanol,≥95%	Full agonist
FPR2/ALX	R342110	528583-91-7	17(R)-Resolvin D1	~0.01% in ethanol,≥95%	Full agonist
BLT1 receptor	R342349	82337-46-0	12(R)-HETE	100 μg/ml in ethanol，98%	Full agonist
GluN1,2A,2B,2C,2D	S105977	312-84-5	D-Serine	>98.5%	Agonist
CaS receptor	S113079	71-44-3	Spermine	for cell culture,≥98.0%(GC)	Full agonist
GPR12	S130679	1670-26-4	Sphingosylphosphorylcholine	>99%	Full agonist
GPRC6 receptor	S137887	56-45-1	L-Serine	Non-animal origin,EP,USP,98.5-101.0%	Full agonist
HCA1 receptor	S161106	10326-41-7	D-Lactic Acid	>90.0%(T)	Partial agonist
HCA2 receptor	S161108	300-85-6	DL-3-Hydroxybutyric Acid (contains Polymolecular esterification product)	>80.0%(T)	Full agonist
mGlu4,mGlu6,mGlu7,mGlu8 receptor	S161191	407-41-0	L-O-Phosphoserine	>98.0%(T)	Full agonist
mGlu3 receptor	S303409	3106-85-2	Spaglumic Acid	98%	Full agonist
GPR119	S351349	111-57-9	Stearoyl Ethanolamide	>98%	Full agonist
succinate receptor	S431423	110-15-6	Succinic acid	For synthesis	Full agonist
GPRC6 receptor	S432937	56-41-7	(S)-(+)-Alanine	For synthesis	Full agonist
GPR119	S465645	19420-57-6	1-Stearoyl-sn-glycero-3-phosphocholine	≥99%, powder	Agonist
Liver X receptor-α,Liver X receptor-β	S491757	77058-74-3	24(S),25-epoxycholesterol	98%	Agonist
5-HT1B,5-HT1D,5-HT1E,5-HT1F,5-HT2A,5-HT2B,5-HT2C,5-HT6,5-HT7 receptor	T101154	61-54-1	Tryptamine	98%	Full agonist
Androgen receptor	T101368	57-85-2	Testosterone propionate	98%	Agonist
TA1 receptor	T105543	51-67-2	Tyramine	98%	Full agonist
Thyroid hormone receptor-α,β	T106193	51-48-9	L-Thyroxine	98%	Agonist
GPR139	T118579	73-22-3	L-Tryptophan	Non-animal origin, EP, JP, USP; For cell culture, 99.0-101.0%	Agonist
Thyroid hormone receptor-α,β	T124580	51-24-1	3,3′,5-Triiodothyroacetic acid	90%	Agonist
DP1,DP2 receptor	T136386	551-11-1	Dinoprost	≥95.0%	Full agonist
EP1,EP2,EP3,EP4 receptor	T136386	551-11-1	Dinoprost	≥95.0%	Full agonist
FP receptor	T136386	551-11-1	Dinoprost	≥95.0%	Full agonist
TP receptor	T136386	551-11-1	Dinoprost	≥95.0%	Full agonist
Thyroid hormone receptor-α,β	T162132	6893-02-3	3,3',5-Triiodo-L-thyronine	>98.0%(HPLC)	Agonist
Pregnane X receptor	T336731	547-96-6	Trihydroxycoprostane		Agonist
LPA5 receptor	T349619	15416-91-8	trans,trans-Farnesyl monophosphate ammonium salt		Agonist
Glycine Receptor (All subtypes)	T431354	107-35-7	Taurine	Ultra-pure biological reagent grade, ≥99.5% (T)	Agonist
GPR84	U109482	112-37-8	Undecanoic acid	Analytical standard,>99.5%(GC)	Agonist
GPR17	U407346	133-89-1	UDP-G	95%	Agonist
P2Y14 receptor	U407346	133-89-1	UDP-G	95%	Full agonist
FFA2,FFA3 receptor	V108269	109-52-4	Valeric acid	Standard for GC,≥99.5%(GC)	Full agonist
Testicular receptor 4	V111674	68-26-8	Retinol	95%	Full agonist
GPR55	V341165	287937-12-6	Virodhamine	98%	Agonist
HCA3 receptor	X139091	617-73-2	(±)-2-Hydroxyoctanoic acid	≥98%	Full agonist
GPR119,55	Z130746	111-58-0	N-Oleoylethanolamine	95%	Agonist
Peroxisome proliferator-activated receptor-α	Z130746	111-58-0	N-Oleoylethanolamine	95%	Agonist

Allosteric Modulator

Target	Cat.No	CAS	Product Name	Specification/Purity	Action
5-HT7 receptor	O105240	301-02-0	Oleamide	70%	Negative
CaS receptor	T118579	73-22-3	L-Tryptophan	Non-animal origin, EP, JP, USP; For cell culture, 99.0-101.0%	Positive
GABAA receptor α1,α2,α3,α4,α5,α6 subunit	T346425	567-03-3	Tetrahydro 11-Deoxycorticosterone		Fortifier
glycine receptor α1 subunit	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Fortifier

Antagonist

Target	Cat.No	CAS	Product Name	Specification/Purity	Action
5-HT2B receptor	M118674	73-31-4	Melatonin	98%	Antagonist
Estrogen-related receptor-α,β,γ	D109025	56-53-1	Diethylstilbestrol	99%	Antagonist
FPR1	C104903	474-25-9	Chenodeoxycholic acid	Analytical standard	Antagonist
FPR1	D103698	83-44-3	Deoxycholic acid	Analytical standard,>99%	Antagonist
LPA2,LPA3,LPA4 receptor	T349619	15416-91-8	trans,trans-Farnesyl monophosphate ammonium salt		Antagonist
Mineralocorticoid receptor	P106427	57-83-0	Progesterone	USP	Antagonist
P2Y1 receptor	A334867	1053-73-2(free acid)	Adenosine 3′,5′-Bisphosphate	98%	Antagonist
RAR-related orphan receptor-β	R106321	302-79-4	Retinoic acid	Analytical standard	Antagonist

Channel Blocker

Target	Cat.No	CAS	Product Name	Specification/Purity	Action
Cav3.1,3.2,3.3	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Antagonist
K2P3.1	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Inhibition
K2P3.1	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Others
KCa2.12.3	S416439	124-20-9	Spermidine	97%	Antagonist
KCa2.1,2.3	S113079	71-44-3	Spermine	for cell culture,≥98.0%(GC)	Antagonist
Kv1.2	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Pore blocker
Kv2.1	L100446	60-33-3	Linoleic acid	Analytical standard,≥99.0%(GC)	Others
Kv4.2	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Others
Maxi Cl-	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Others
TRPC5	P106427	57-83-0	Progesterone	USP	Inhibition
TRPM4	A501266	56-65-5	Adenosine triphosphate	90%	Antagonist
TRPM4,5,7	S113079	71-44-3	Spermine	for cell culture,≥98.0%(GC)	Antagonist
TRPM4	A108808	58-61-7	Adenosine	Ultra pure grade,99.5%	Others
TRPM7	D130604	123-78-4	D-erythro-sphingosine	>99%	Inhibition
TRPM8	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Others
TRPM8	L100446	60-33-3	Linoleic acid	Analytical standard,≥99.0%(GC)	Others
TRPV3	R342110	528583-91-7	17(R)-Resolvin D1	~0.01% in ethanol,≥95%	Inhibition
VRAC	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Others

Gating Inhibitor

Target	Cat.No	CAS	Product Name	Specification/Purity	Action
CNGA2	A122355	116-31-4	all trans-Retinal	≥98%	Antagonist
Kir6.1,6.2	A501266	56-65-5	Adenosine triphosphate	90%	Antagonist
KNa1.2	A501266	56-65-5	Adenosine triphosphate	90%	Others
TRPA1	M105139	89-78-1	DL-Menthol	Analytical standard	Inhibition
TRPA1	R341442	872993-05-0	Resolvin D1	A solution in ethanol,≥95%	Inhibition
TRPM4	A136967	61-19-8	5'-Adenylic Acid	≥98.0%(HPLC)	Antagonist
TRPM4	A119474	58-64-0	Adenosine 5′-diphosphate	≥95% (HPLC)	Antagonist
TRPM4	A501266	56-65-5	Adenosine triphosphate	90%	Antagonist

Inhibitor

Target	Cat.No	CAS	Product Name	Specification/Purity	Action
carbonic anhydrase 1	G131992	149-91-7	Gallic acid	99%	Inhibition
Cx23,25,26,30,30.2,30.3,31,31.1,31.9,32,36,37,40,40.1,43,45,46,47,50,59,62	O119679	111-87-5	n-Octanol	Waterless grade,≥99%	Others
CYP19A1	E129476	107868-30-4	Exemestane	≥99%	Inhibition
Glutamic acid decarboxylase 1,2	A115225	16338-48-0	(S)-(-)-2-Amino-4-pentenoic acid	98%	Inhibition
histone deacetylase 1,2,3,8	B110439	107-92-6	Butyric acid	Standard for GC,>99.5%(GC)	Inhibition
K2P18.1	A111764	506-32-1	Arachidonic acid	Analytical standard,≥99.0%(GC)	Others
K2P9.1	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Others
L-Phenylalanine hydroxylase	M166002	1132-26-9	α-Methyl-DL-phenylalanine	98%	Inhibition
L-Tyrosine hydroxylase	B301360	672-87-7	alpha-Methyl-L-tyrosine	≧95%	Inhibition
major facilitator superfamily domain containing 4B	U141075	57-13-6	Urea	≥99.5%	Inhibition
OATP1C1	T336942	81-24-3	Taurocholic Acid	98%	Inhibition
phosphatidylinositol 4-kinase type 2 alpha,beta	A108808	58-61-7	Adenosine	Ultra pure grade,99.5%	Inhibition
phosphodiesterase 3A,3B	G349525	7665-99-8	Guanosine 3′,5′-cyclic monophosphate	≥98%	Inhibition
Proton-coupled Amino acid Transporter 1	E110147	50-28-2	β-Estradiol	Analytical standard,99.5%	Inhibition
Proton-coupled Amino acid Transporter 1,2	H111084	4350-09-8	5-Hydroxy-L-tryptophan	99%	Inhibition
Proton-coupled Amino acid Transporter 1	H303833	50-67-9	5-Hydroxytryptamine	≥98%（HPLC）	Inhibition
Proton-coupled Amino acid Transporter 1	E129595	57-63-6	Ethinyl Estradiol	≥98%	Inhibition
Proton-coupled Amino acid Transporter 1	T118579	73-22-3	L-Tryptophan	Non-animal origin, EP, JP, USP; For cell culture, 99.0-101.0%	Inhibition
Sodium/bile acid and sulphated solute cotransporter 1	U110696	128-13-2	Ursodeoxycholic acid	Analytical standard	Inhibition

Subunit-specific

Target	Cat.No	CAS	Product Name	Specification/Purity	Action
Glycine Receptor (All subtypes)	D106380	53-43-0	trans-Dehydroandrosterone	99%	Inhibition
Glycine Receptor (All subtypes)	P106427	57-83-0	Progesterone	USP	Inhibition
Glycine Receptor (All subtypes)	A274932	94421-68-8	Arachidonylethanolamide	≥98%	Fortifier
Glycine Receptor (All subtypes)	P129412	145-13-1	Pregnenolone	98%	Fortifier

Others

Target	Cat.No	CAS	Product Name	Specification/Purity	Action
ABCB11	G304255	640-79-9	Glycochenodeoxycholic acid	>98%	Binding

Aladdin：https://www.aladdinsci.com/

Categories: Technical articles

Explore topics: Bioactive Small Molecules Metabolites

Was this article helpful? 1 out 3 found this helpful